Literature DB >> 5302327

A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

W H Mosley, A S Benenson, R Barui.   

Abstract

Controlled cholera vaccine field trials were held in Matlab Bazar in rural East Pakistan in 1963 and 1964. In July-September 1965, a serological survey for cholera antibodies was carried out on a random sample of the field-trial population. Results are given for the control group only, as representative of the pattern found in an endemic cholera area. Only 2% of the blood samples from children under 10 years of age were found to have detectable agglutinating antibody (titres of 1:20 or more), while the proportion in the age-group over 30 years was 27%-30%. Tests for vibriocidal antibody showed that none of the blood samples from children under 1 year of age contained detectable antibody, while 87%-90% of those from adults over 30 years did so. The rise in the geometric mean vibriocidal titre showed an almost linear correlation with a sharp fall in the cholera case rate with age. Since a similar survey in a non-endemic area (Czechoslovakia) did not reveal any rise in antibody titre with age, and since cholera epidemics in areas without recent experience of the disease are characterized by a higher incidence rate in adults than in children, it is suggested that the antibody titres give a measure of the level of immunity in a population.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5302327      PMCID: PMC2554484     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  FIELD TRIAL OF CHOLERA VACCINE IN RURAL EAST PAKISTAN. FIRST YEAR OF OBSERVATION.

Authors:  R O OSEASOHN; A S BENENSON; M FAHIMUDDIN
Journal:  Lancet       Date:  1965-02-27       Impact factor: 79.321

2.  A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

3.  Studies of cholera El Tor in the Philippines. I. Characteristics of cholera El Tor in Negros Occidental Province, November 1961 to September 1962.

Authors:  J J Dizon; M G Alvero; P R Joseph; J F Tamayo; W H Mosley; D A Henderson
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

4.  Clinical and bacteriological findings among families of cholera patients.

Authors:  R Oseasohn; S Ahmad; M A Islam; A S Rahman
Journal:  Lancet       Date:  1966-02-12       Impact factor: 79.321

5.  A RECENT STUDY OF CHOLERA WITH REFERENCE TO AN OUTBREAK IN TAIWAN IN 1962.

Authors:  C H YEN
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

6.  Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.

Authors:  A S Benenson; W H Mosley; M Fahimuddin; R O Oseasohn
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

7.  Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.

Authors:  A S Benenson; A Saad; W H Mosley
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

8.  Serological studies in cholera. I. Vibrio agglutinin response of cholera patients determined by a microtechnique.

Authors:  A S Benenson; A Saad; M Paul
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

  8 in total
  46 in total

1.  Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139.

Authors:  Stephen R Attridge; Camilla Johansson; Dang D Trach; Firdausi Qadri; Ann-Mari Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

3.  Type-specific action of vibriocidal antibody on Vibrio cholerae.

Authors:  A H Pykett; N W Preston
Journal:  J Hyg (Lond)       Date:  1975-12

4.  Serotype cycles in cholera dynamics.

Authors:  Katia Koelle; Mercedes Pascual; Md Yunus
Journal:  Proc Biol Sci       Date:  2006-11-22       Impact factor: 5.349

5.  Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Rina Saksena; Alaullah Sheikh; Mohammad Murshid Alam; Firdausi Qadri; Stephen B Calderwood; Pavol Kovác; Edward T Ryan
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

6.  An overview of VaxchoraTM, a live attenuated oral cholera vaccine.

Authors:  Tarun Saluja; Vijayalaxmi V Mogasale; Jean-Louis Excler; Jerome H Kim; Vittal Mogasale
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

7.  Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults.

Authors:  S Migasena; P Pitisuttitham; B Prayurahong; P Suntharasamai; W Supanaranond; V Desakorn; U Vongsthongsri; B Tall; J Ketley; G Losonsky
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

8.  Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.

Authors:  Ana A Weil; Fahima Chowdhury; Ashraful I Khan; Daniel T Leung; Taher Uddin; Yasmin Ara Begum; Nirod Chandra Saha; Richelle C Charles; Regina C Larocque; Jason B Harris; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  Am J Trop Med Hyg       Date:  2012-09-10       Impact factor: 2.345

9.  Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Authors:  Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

10.  The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.

Authors:  Muhammad Asaduzzaman; Edward T Ryan; Manohar John; Long Hang; Ashraful I Khan; A S G Faruque; Ronald K Taylor; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.